Search research articles
Contact Us
Filters
Showing results (451-460 of 490) with videos related to
Page
of 49
Sort By:
Nature
|
December 14, 2004
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
Photini Kiepiela, Alasdair J Leslie, Isobella Honeyborne, et al.
Nature
|
March 24, 2016
Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.
JCI Insight
|
March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site
Hao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
CD8<sup>+</sup> T cell recall cytotoxicity during chronic treated HIV-1 infection is associated with limited reservoir size and activity
David R Collins, Mpho J Olatotse, Jonathan M Urbach, et al.
Plos Pathogens
|
April 16, 2016
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
R Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.
Science Translational Medicine
|
September 30, 2016
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection
Maximilian Muenchhoff, Emily Adland, Owen Karimanzira, et al.
Nature Immunology
|
December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
Nicole Frahm, Photini Kiepiela, Sharon Adams, et al.
Nature Medicine
|
December 19, 2006
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela, Kholiswa Ngumbela, Christina Thobakgale, et al.
Nature
|
April 10, 2015
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.
Science Translational Medicine
|
November 29, 2023
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
Reza Zonozi, Lucy C Walters, Aaron Shulkin, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 490) with videos related to
Sort By:
Page
of 49
Nature
|
December 14, 2004
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
Photini Kiepiela, Alasdair J Leslie, Isobella Honeyborne, et al.
Nature
|
March 24, 2016
Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.
JCI Insight
|
March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site
Hao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
CD8<sup>+</sup> T cell recall cytotoxicity during chronic treated HIV-1 infection is associated with limited reservoir size and activity
David R Collins, Mpho J Olatotse, Jonathan M Urbach, et al.
Plos Pathogens
|
April 16, 2016
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
R Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.
Science Translational Medicine
|
September 30, 2016
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection
Maximilian Muenchhoff, Emily Adland, Owen Karimanzira, et al.
Nature Immunology
|
December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
Nicole Frahm, Photini Kiepiela, Sharon Adams, et al.
Nature Medicine
|
December 19, 2006
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela, Kholiswa Ngumbela, Christina Thobakgale, et al.
Nature
|
April 10, 2015
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.
Science Translational Medicine
|
November 29, 2023
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
Reza Zonozi, Lucy C Walters, Aaron Shulkin, et al.
Page
of 49